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HIV-1 reverse transcriptase (RT) contains both DNA polymerase
and RNase H activities to convert the viral genomic RNA to dsDNA
in infected host cells. Here we report the 2.65-Å resolution struc-
ture of HIV-1 RT engaging in cleaving RNA in an RNA/DNA hybrid.
A preferred substrate sequence is absolutely required to enable
the RNA/DNA hybrid to adopt the distorted conformation needed
to interact properly with the RNase H active site in RT. Substituting
two nucleotides 4 bp upstream from the cleavage site results in
scissile-phosphate displacement by 4 Å. We also have determined
the structure of HIV-1 RT complexed with an RNase H-resistant
polypurine tract sequence, which adopts a rigid structure and is
accommodated outside of the nuclease active site. Based on this
newly gained structural information and a virtual drug screen, we
have identified an inhibitor specific for the viral RNase H but not
for its cellular homologs.
RNase H | sequence specificity | polypurine tract | minor groove
recognition | connection domain
HIV is the cause of the global AIDS pandemic. More than70 million people have become infected, 35 million have
died from AIDS-related illness, and 36.7 million people are
currently living with HIV. HIV encodes four enzymatic activities:
a protease, an integrase, a DNA polymerase, and RNase H. The
latter two reside in a single polypeptide chain of the hetero-
dimeric reverse transcriptase (RT) (1). Structures of HIV-1 RT
engaging in DNA synthesis have been determined (2–4). How
RT is inhibited by nonnucleoside (NNRTIs) and nucleotide-like
RT inhibitors (NRTIs), and how drug resistance arises have been
well established (5–7); however, how RNase H recognizes and
cleaves viral genomic RNA in an RNA/DNA hybrid but spares
polypurine tract RNA, which serves as the primer for DNA
synthesis, has not emerged from previous structural studies.
Because the molecular mechanisms underlying HIV-1 DNA
polymerase, integrase, and protease activities have been estab-
lished, their active sites have been successfully targeted using
rational drug design to develop AIDS therapies (8). RNase H is
the sole HIV-1–encoded enzyme for which no drug exists.
Hundreds of structures of HIV-1 RT, ranging from the apo
form to complexes with inhibitors, nucleic acid substrates, or
both, have been determined by X-ray crystallography. Its two
subunits, p51 and p66, share the same coding sequence but have
different tertiary structures (2, 5, 7). Both the polymerase and
RNase H active sites reside in p66, and p51 plays a supportive
role. The p51 subunit lacks the C-terminal RNase H domain,
while the remaining fingers, thumb, palm, and connection do-
mains undergo extensive domain rearrangement in comparison
with p66 (Movie S1). The overall structure of RT is elongated,
with the polymerase active site near one end and the RNase H
60 Å away at the other end.
In the HIV-1 RT structure captured in the DNA synthesis
mode (2), the DNA duplex passes by the RNase H active site at a
distance of at least 5.5 Å. The first structure of HIV-1 RT and an
RNA/DNA hybrid complex, in which the RT was cocrystallized
with “nucleic acid” without specification of RNA or DNA and
then soaked in RNA/DNA hybrid, was reported in 2001 (9). The
resulting structure of the purported RNA/DNA hybrid [Protein
Data Bank (PDB) ID code 1HYS] is superimposable with the
DNA duplex complexed with RT (PDB ID code 2HMI) reported
by the same group (10) (SI Appendix, Fig. S1), and the RNA
strand has severe steric clashes between adjacent O2′ and O4′
because of the overall B-form conformation of the hybrid (www.
rcsb.org/pdb/explore.do?structureId=1hys; SI Appendix, Fig. S2).
Whether an RNA/DNA hybrid or a DNA duplex, in these RT
structures the closest approach between the nucleic acid back-
bone and the RNase H active site is 6.5 Å, and RNase H is not
engaged in catalysis.
However, the difficulty in capturing the RNA strand in the
RNase H active site of HIV RT stems not only from this dis-
tance, but also from the conformation of RNA/DNA hybrids. In
contrast to the cellular RNases H, which recognize 4–10 bp of a
hybrid and have little sequence preference (11, 12), HIV-1 RT
binds a nucleic acid duplex of 20–22 bp from the DNA poly-
merase domain to beyond the RNase H active site (13). Struc-
tures of cellular RNase H complexed with an RNA/DNA hybrid
in which the RNA strand is poised for cleavage have been de-
termined (14, 15). When superimposing the “active” form of a
cellular RNase H-RNA/DNA complex onto RT-substrate com-
plexes (2), we find that the 20-bp duplex bound to RT must be
unwound and bent in the middle to place the RNA strand in the
viral RNase H active site for cleavage (15).
In 2013, we reported a 3.3-Å cocrystal structure of HIV-1 RT
and an RNA/DNA hybrid in the presence of the NNRTI efa-
virenz (EFV), which enhances RNase H activity and inhibits
DNA polymerase by keeping RT in an open inactive form (16).
The RNA/DNA hybrid is significantly underwound just upstream
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of the RNase H active site. The curvature and orientation of the
RNA strand are compatible for cleavage, but the scissile phos-
phate remains >4 Å away from the HIV-1 RNase H active site.
After screening various lengths and sequences of DNA/RNA
hybrids, we have obtained a cocrystal structure of an HIV-1 RT–
RNA/DNA hybrid at 2.65-Å resolution, in which just two base
pairs of the hybrid upstream from the scissile phosphate are
changed and the RNA strand is poised for cleavage by the RNase
H. Furthermore, we have obtained three additional cocrystal
structures of HIV-1 RT with different RNA/DNA hybrids at
resolutions ranging from 2.44 to 3.25 Å that reveal the importance
of substrate sequence for viral RNase H cleavage.
Results
Finding a Sequence Efficiently Cleaved by HIV-1 RNase H. Our initial
structure of an RT-substrate complex contains a 22-bp RNA/
DNA hybrid with a 5′-RNA overhang of 5 nt, which includes an
abasic site at the templating position to inhibit DNA synthesis
(Fig. 1A; R1R2/D2). The RNA strand is composed of two oligos
(10 and 17 nt) for the purpose of efficient crystallization
screening (16), and the resulting RNA/DNA hybrid contains a
designed nick (Fig. 1A). The phosphate nearest to the RNase H
active site is 19 bp from the 3′ end of the DNA strand and 7 bp
from the nick (Fig. 1 A and B) (16). This potential scissile
phosphate is well oriented but outside of the RNase H cleavage
site. Initially, we suspected that this displacement from the
cleavage site was due to crystal lattice contacts made by the
RNA/DNA hybrid, and we tried to alter lattice contacts by
varying the ends of the RNA/DNA hybrid. After many failures,
we realized that the RNA/DNA substrate has an unsuitable se-
quence (Fig. 1B).
Compared with RNA sequences efficiently cleaved by HIV-1
RNase H (17), uracil and adenine (UA) at the −5 and −4 positions
from the cleavage site in our initial RNA/DNA substrate are
disfavored by RNase H (Fig. 1B). When we change the sequence
of the second half of the hybrid from the nonpreferred UA (R2) to
the preferred guanine-uracil sequence (R54, the 54th RNA tried in
the RT project), the cleavage sites and efficiency of these hybrids
change dramatically in solution (Fig. 1). The R2 hybrid is not
cleaved at the 19th base pair as crystallized, which would generate a
7-nt product. Instead, a 6-nt product (Fig. 1 A and C) cleaved 18 bp
from the 3′ end of DNA is generated because by shifting 1 bp, the
−2, −4, and −5 positions have the preferred sequence (Fig. 1 B and
C). In contrast, the R54 hybrid is cleaved efficiently at 19 bp from
the DNA 3′ end and less efficiently at 18 bp, generating 7- and 6-nt
products, respectively (Fig. 1C). In single turnover reactions, the
R54 hybrid is more efficiently cleaved than the R2 hybrid (Fig. 1D),
and the 7-nt cleavage product of the R54 hybrid is more abundant
than the 6-nt product. The combined cleavage efficiency of
R54 hybrid (6 and 7 nt) is at least threefold higher than that of the
R2 hybrid (Fig. 1D), and the cleavage efficiency of the R54 hybrid
at 19 bp (7-nt product) is infinitely greater than the undetectable
cleavage at the corresponding site in the R2 hybrid. For a reputedly
non–sequence-specific nuclease, the difference made by a 2-bp
change was surprising.
We further tested the RNase H cleavage of a polypurine tract
sequence (R67) by changing the second half of the hybrid
while retaining the sequence of the first half that contacts the
DNA polymerase domain (R1) (Fig. 1A). Unsurprisingly,
cleavage of the R67 hybrid is barely detectible in a single-
turnover assay (Fig. 1D). With prolonged incubation in a
steady-state reaction, the sole detectable product is 6 nt, and
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Fig. 1. Sequence preference of HIV-1 RT for RNase H cleavage. (A) Three
sequence variations of RNA/DNA hybrids for cleavage and cocrystallization
with RT. R60 is similar to R1 but 2 nt shorter (gray) on the 5′-end. * indicates
the 5′-end of the second RNA strand after the prenick. The preferred RNase H
cleavage site of each substrate is indicated by a vertical arrowhead. (B) Se-
quence comparison of two alternative cleavage sites of the three RNA/DNA
variations shown in Awith the known favorable sequence (17). The forbidden
adenine at position −4 is highlighted in red. (C and D) Extended (C) and
single-turnover (D) assays of cleaving three substrate variations by HIV-1 RT.
The size markers correspond to the 6- and 7-nt cleavage products of R54.
Fig. 2. The RT-RNA/DNA structure in crystal 1. (A) Closeup stereoview of
the RNase H active site. The arrowhead marks the nucleophilic attack of the
scissile phosphate. Coordination of the two Ca2+ ions is indicated by the
dashed lines. Oxygen atoms are shown in red, nitrogen in blue, and water
molecules in pink or red (nucleophile). (B) Stereoview of the superposition of
human RNase H1 and HIV-1 RT. The cellular RNase H is shown in pink, with
the RNA and DNA in light orange and blue, respectively. The retroviral
RNase H is shown in light green, and the RNA/DNA hybrid is in orange and
blue. In addition to the catalytic carboxylates, H539 and R557 of RT are
shown as sticks.
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not 7 nt (Fig. 1C), likely because Ade at the −2 position is un-
favorable (Fig. 1B). The RNA cleavage results of these hybrids by
HIV-1 RT agree with the preferred sequence identified by Schultz
et al. (17), and support the importance of the −2 (favoring G/C)
and −4 positions (disfavoring A) for determining substrate specificity.
Crystal Structure of the HIV-1 RNase H Engaged in RNA Cleavage.We
obtained RT cocrystals with all three RNA/DNA hybrids shown in
Fig. 1A in the presence of Ca2+ and EFV. Wild-type RT was used,
and the catalytic cofactor Mg2+ was replaced with Ca2+, which
supports enzyme-substrate complex formation but not catalysis (15,
18, 19). The diffraction quality of these crystals was improved by
trimming the 5′-overhang on the RNA strand from 5 nt to 3 nt
(R60), and by coexpression and copurification of RT p51 and
p66 subunits rather than mixing of the cell lysates of individually
expressed subunits before purification (16). Two different types of
cocrystals with the RNase H-favored sequence (R54) were obtained,
one with a single dG overhang at the 5′-end of the DNA strand
(crystal 1) and the other with a dCG dinucleotide overhang
(crystal 2), with X-ray diffraction to 2.65 and 2.44 Å, respectively
(SI Appendix, Table S1). With the 2-nt trimmed RNA template
and the modified protein preparation procedure, the RNase H-
disfavored sequence (R2) produced a 2.89-Å structure (crystal 3;
SI Appendix, Table S1), which is an improvement from the origi-
nal 3.3 Å (PDB ID code 4B3O) (16). Despite the resolution im-
provement and the small but discernible structural changes in the
finger and thumb domains of RT and the second half of the RNA/
DNA hybrid (SI Appendix, Fig. S3), the scissile phosphate of the
RNA remained outside of the RNase H active site in crystal 3.
Finally, we produced cocrystals of RT with the R67 polypurine
tract hybrid (crystal 4; SI Appendix, Table S1), which resulted in
a 3.25-Å structure.
All of these crystals are in the P3121 space group and iso-
morphous to the previously published structure, 4B3O (16). In
the four newly refined structures, the potential scissile phosphate
on the RNA strand (closest to the RNase H active site) is always
19 bp from the 3′-end of the DNA strand and 7 bp from the nick
site (Fig. 2 and SI Appendix, Fig. S4). Consequently, only R54
RNA presents a favorable sequence for RNase H cleavage within
the crystal lattice. In crystal 1 (R54), the scissile phosphate is
ideally situated in the RNase H1 active site, and the active site is
completed with two Ca2+ ions (Fig. 2A). The A site Ca2+ ion,
which has six ligands including nucleophilic water, and the B site
Ca2+ ion, are coordinated by the four conserved active site carbox-
ylates and the scissile phosphate, similar to the two divalent cations
bound in the active site of cellular RNase H1 (14, 15) (Fig. 2B).
The proper positioning of the RNA strand and scissile phos-
phate for RNase H cleavage by RT can be easily perturbed by
slight changes of crystal lattice contacts, as demonstrated in
crystal 2. With just one additional nucleotide at the 5′-end of the
DNA primer, 4 bp of the hybrid, including the scissile phosphate,
pivots away by 2 Å from the RNase H active site and by 3.5 Å
near the DNA 5′-end (SI Appendix, Fig. S4A). The pivoted RNA
strand is no longer poised for cleavage. If higher resolution and
lower B factors are indicators of increased structural stability, the
RNase H active configuration in crystal 1 is likely a less-stable
Fig. 3. Interactions of RNase H with RNA/DNA hybrids. (A) Stereoview of the sharp turn at the −3 position in crystal 1. The RNA/DNA hybrid is shown as blue
(DNA) and pink (RNA) sticks. The scissile phosphate is shown in orange, and the −3 phosphate of the DNA strand is highlighted in red. Protein side chains
contacting the RNA/DNA hybrid (yellow) and the active site (pink) are shown in ball-and-stick representation. The Ca2+ ions are shown as green spheres. (B)
Bending of the RNA/DNA hybrid at the −3 position in Crystal 1. Seven base pairs (−5 to +2) are shown, with −1 to −4 in darker colors. (C) The lack of
corresponding RNase H–RNA/DNA interactions and absence of the deformation of the RNA/DNA hybrid in crystal 3.
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and higher-energy state than the RNase H inactive configuration
in crystal 2.
Reasons for the strong sequence bias of retroviral RNase H
are revealed by the structures of crystals 3 and 4. The difference
resulting from the 2-nt substitution between R54 (crystals 1 and
2) and R2 substrate (crystal 3) is dramatic (SI Appendix, Fig.
S4B). Of the two halves of the RNA/DNA hybrid (before and
after nick), the first half near the polymerase domain changes
little, but the duplex curvature of the second half, which is bound
to the RNase H domain, deviates significantly. Together with a
clamshell-like slight opening of the p66 subunit (resulting in
an increased distance between the polymerase and RNase H
active site), the noncleavable hybrid (R2 in crystal 3) is less con-
tracted than the preferred sequence (R54 in crystal 1), and the
scissile phosphate is ∼2.5 Å further from the RNase H active site
in crystal 3 (Fig. 3; SI Appendix, Fig. S4B; and Movie S2).
The structure of the polypurine tract in crystal 4 shows a
straighter hybrid (R67) due to the strong base stacking of poly-
purines and a more extended RT to accommodate the stiffer and
more extended hybrid than that in crystal 3 (R2). The scissile
phosphate of R67 is displaced by >4 Å from the cleavage
position. Surprisingly, dT at the −5 position from the scissile
phosphate is flipped out of the duplex and into a cavity be-
tween the p51 and p66 subunits. This cavity exists only when
RNase H is complexed with an RNA/DNA hybrid (R2, R54,
or R67). The significance and implication of this cavity is
discussed below.
Key Interactions Dictate the Sequence Context for RNA Cleavage.
The distortion of the RNA/DNA hybrid that leads to position
the scissile phosphate in the RNase H active site occurs at 3 bp
upstream (−3 position) from the scissile phosphate. The DNA
strand is pushed away from the protein by Y501, Q475, and
N474, and the RNA strand is pulled in by Q500 (Figs. 3A and 4).
The adjacent deoxyribonucleotides (−1 and −2) are surrounded
by R448, T473, N474, Q475, and K496. The tight interactions of
R488, Q475, and Y501 with the phosphosugar backbone exclude
2′-OH groups at the −1 to −3 positions (Fig. 3A) and are thus
specific for DNA in the hybrid. Specificity for the RNA strand is
achieved chiefly by the active site residues and Q500, which form
hydrogen bonds with the −2 and −3 riboses (Fig. 3 A and B).
Such “reading” of RNA/DNA hybrids is conserved in cellular
RNase H1 (Fig. 2B) (14, 15).
The sharp bend at the −3 position coupled with a severe tilt
and shift of the DNA base to the major groove leads to the se-
quence preference observed for HIV-1 RNase H. If dT were at
the −4 position, then the methyl group on its C5 would clash
severely with both the base and deoxyribose at the −3 position
(<2.4 Å) (Fig. 3B). Adenine is disfavored in the RNA strand at the
−4 position, most likely to avoid the dT opposite it. When the
RNA at −4 is an adenine as in the R2 hybrid, there is no bend
at the −3 position, and its phosphate backbone is >4 Å further
from Y501 than that of the R54 hybrid (Fig. 3 B and C). In the
absence of close contacts with RT, the R2 hybrid is more re-
laxed than R54, and its scissile phosphate is 2.5 Å away from
the RNase H active site. Owing to the sharp turn in the RNase
H active form, the base pair at the −2 position assumes a strong
propeller twist (Fig. 3 A and B), which may explain why a −2 G/C
base pair with three hydrogen bonds is favored over A/T for
RNase H cleavage (Fig. 1B).
Two Competing Modes of HIV1-1 RT for DNA Synthesis and RNA
Degradation. To convert from the DNA synthesis to the RNA
hydrolysis mode, RT undergoes a seesaw motion. If we super-
impose the thumb domains (p66) of the two functional modes
and thus leave the 3′-end of the primer anchored in the poly-
merase active site, the finger domain moves away from the
thumb (opening) and the RNase H domain moves toward the
thumb, thus closing the gap between them, while the RNA/DNA
hybrid after the midpoint (from the 3′-primer end) becomes
underwound and tilted toward the RNase H active site (Fig. 4
and Movie S3). The closing of the thumb and RNase H domains
Fig. 4. The cavity between p66 and p51 in the RNA cleavage mode. (A and
B) Front (A, cartoon) and back (B, space-filling) views of crystal 1, repre-
senting the RNA degradation mode. (C and D) Front (C) and back (D) views
of RT engaging in the RNA-templated DNA synthesis (PDB ID code 4PQU).
The thumb domains (p66) of the two structures are superimposed. The three
loop regions that undergo extensive conformational changes between
the RNA degradation and DNA synthesis modes are highlighted in magenta.
The cavity at the p51-p66 interface in the RNA degradation mode (B)
and the corresponding region in the DNA polymerization mode (D) are
boxed in cyan.
Fig. 5. The competing DNA synthesis and RNA hydrolysis modes of RT.
(A) Single-turnover assay of RNase H cleavage (of R54) by HIV-1 RT alone and in
the presence of 100 μM EFV or 500 μM dAMPNPP. The 32P-labeled R54 is
preferably cleaved 19 bp from the 3′-end of the DNA to produce 7 nt. In the
presence of dAMPNPP, the cleavage site is shifted to 18 bp from the 3′-DNA,
and cleavage efficiency is reduced. (B) Single-turnover assays of dATP in-
corporation into R54, R2, and R67 hybrids by the RNase H-inactivated HIV-1 RT
(D498N). DNA primers are 5′-labeled with fluorescein amidite.
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requires significant repacking of three loops (G333-G335,
A355-N363, and Q509-S513), as described previously (16).
Furthermore, the p51-p66 subunit interface is altered. In the
RNA degradation-compatible mode, the two RT subunits are
further apart at the fingers-fingers and connection-connection
interfaces.
Looking from the back side of the RT (opposite from where
nucleic acid substrate binds), an oval-shaped cavity of 8 × 12 Å
appears between the p51 and p66 subunits when RT is in the
RNA-degradation–compatible mode, and the deoxyribonucleo-
tides at the −4 and −5 positions from the RNase H cleavage site
become solvent-exposed on both major and minor groove sides
(Fig. 4 A and B). The cavity, which persists in crystals 1–4 and
4B3O (16), is the largest when dT at the −5 position is flipped
into it in crystal 4. This cavity disappears in the DNA synthesis
mode, and the minor groove side of nucleic acid substrate is
shielded from the bulk solvent whether the template is DNA or
RNA (PDB ID codes 1RTD, 3KK2, and 4PQU) (2–4) (Fig. 4 C
and D).
Whether DNA synthesis and RNA degradation can occur si-
multaneously has been a topic of debate (20, 21). It is well
established that DNA synthesis occurs more frequently and at a
much faster rate than RNA hydrolysis during reverse transcrip-
tion (22). As detailed above, the two functional states of RT are
structurally nonequivalent. It has been reported that engaging
the DNA 3′-end in the synthesis mode inhibits RNA degradation
(23), while inhibition of DNA synthesis by NNRTIs promotes 3′-
DNA–directed RNA degradation (24, 25). Using the RNA/DNA
hybrid preferred by RNase H hydrolysis (R54) in single-turnover
assays, we confirmed that inhibition of DNA synthesis by the
NNRTI EFV enhances RNA hydrolysis (Fig. 5A). The presence
of EFV in cocrystals of RT and RNA/DNA likely stabilizes the RNA
degradation mode. In contrast, prolonged engagement of DNA
polymerization by a nonreactive nucleotide analog (dAMPNPP)
reduces RNA hydrolysis (Fig. 5A).
We then asked whether engaging in RNA degradation reduces
the efficiency of DNA synthesis. To do so, we conducted single-
turnover assays of the RNase H-defective RT (D498N) using
preferred (R54), nonpreferred (R2), or polypurine tract (R67)
RNA/DNA hybrids. We found that incorporation of dATP is
most efficient with the RNase H-resistant polypurine tract and
least efficient with the RNase H-preferred substrate (Fig. 5B).
To eliminate the possibility that such differences are due to
different substrate affinities, we determined the overall binding
constants of these hybrids to RT and found them to be similar,
ranging from 6.7 nM to 10.4 nM (SI Appendix, Fig. S5). These
data indicate that local conformation of RNA/DNA hybrids
around the RNase H active site influences the rate of DNA
synthesis. The better the hybrid binds to the RNase H active site,
the less DNA synthesis occurs. The incompatible structures and
the competing nature of RNA degradation and DNA synthesis
suggest that RT cannot perform the two functions simultaneously.
An Inhibitor of RT Targeting the p51-p66 Interface. The cavity be-
tween the p51 and p66 subunits 4–5 bp upstream from the RNase
H cleavage site provides a site for small molecules to bind to RT.
Using this cavity as a target and an in-house developed virtual
screening pipeline (LvsPipe) (26), we screened 260,000 com-
pounds in the NCI DTP (Developmental Therapeutics Program)
library and identified potential inhibitors. We obtained 46 com-
pounds from DTP and tested them in fluorescence-based RNA/
DNA substrate binding, RNase H, and DNA polymerase activity
assays. Three compounds inhibited nucleic acid binding and both
enzymatic activities of HIV-1 RT, and the best one inhibited all
three activities at 10–15 μM and had no effect on bacterial and
human RNase H1 (Fig. 6). The mechanism of action of these
inhibitors differs from that of the NRTIs and NNRTIs currently
in clinical use, which do not inhibit either substrate binding or
RNase H activity, but is consistent with the expected effects of
interfering with the p51-p66 interface.
Discussion
Our determination of an RT structure with RNA substrate in the
RNase H active site reveals the factors that prevented crystalli-
zation of HIV-1 RT in the RNA degradation mode in previous
studies. Although the RNase H activity of RT is reported to be
sequence-dependent (17, 27), the mechanism has remained un-
clear until now. We find that the strong sequence preference is
due to a distorted substrate structure necessary for RNase H
cleavage rather than base-specific interactions with the protein.
An rA/dT pair at the −4 position prevents the necessary struc-
ture distortion for RNA degradation and thus is incompatible
with RNase H cleavage. In solution, HIV-1 RT is able to find
preferred sequences in most substrates. In crystals, because the
substrate cannot slide relative to RT as in solution, the sequence
effect is binary: cut or no cut (Figs. 1 and 3). The lack of proper
crystal lattice contacts and a favorable sequence for RNase H
cleavage explains the 2-decade absence of an HIV-1 RT structure
in the RNA degradation mode. Despite the report of sequence
preference by retroviral RNases H in 2009 (27), unfavorable se-
quences are continuously used in kinetic and structural studies of
HIV-1 RNase H (4, 20).
The severely distorted substrate conformation for RNase H
cleavage appears to be favored by the nick that we introduced for
crystallization, and crystals obtained with the nicked RNA diffract
X-rays to higher resolutions compared with those without the nick
in the RNA (16). Nevertheless, in solution, RNA cleavage by RT
occurs at the same sites and with similar efficiencies regardless of
whether or not the RNA strand is prenicked (SI Appendix, Fig. S6).
Lattice contacts formed by the polymerase domains, which
have been suggested to explain the inactive RNase H (28), have
no effect, as we had foreseen (29), and are confirmed to be in-
consequential here. Between the DNA synthesis and RNA
degradation modes, the thumb domain, which forms the primer
grip adjacent to the polymerase active site, interacts similarly
with RNA/DNA and DNA/DNA duplexes (Fig. 4). This may
Fig. 6. Characterization of an RT inhibitor targeting the p51-p66 interface.
(A) Three compounds from the NCI DTP library inhibit the fluorescence-labeled
RNA/DNA hybrid binding to RT at various concentrations in the presence of Ca2+.
(B) Structure diagram of NSC73416. Diagrams of the other two compounds are
provided in SI Appendix, Fig. S8. (C) NSC73416 inhibits the HIV-1 RNase H with
IC50 = 12 μM, but has no effects on human (Hs) or bacterial (Bh) RNase H1.
(D) NSC73416 inhibits the HIV-1 polymerase activity with IC50 = 10 μM.
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explain why RNA is still hydrolyzed by RNase H when the DNA
end is cross-linked to the thumb or polymerase active site (21).
Between the two functional modes of RT, the p51-p66 interface
changes substantially from the fingers domain to the RNase H do-
main (Movie S3). Conversion of RT from DNA synthesis mode to
RNA degradation mode by soaking crystals in an NNRTI solution
(nevirapine) leads to significant changes at the fingers interface of
p51-p66 but not at the connection interface or the RNase H domain,
so the result is an incomplete switch and an unengaged RNase H
active site (PDB ID code 4PUO) (4) (SI Appendix, Fig. S7). In-
terconversion of the two RT functional states might not be kineti-
cally detectable (20) if it occurs faster than hydrolysis by RNase H;
however, the two modes have evidently different structures, compete
for a shared substrate, and may not occur simultaneously.
Competition for substrate by RNase H naturally decreases the
dwelling time of an RNA/DNA hybrid in the polymerase active
site, and thus may reduce the chance of incorporating mismatched
dNTPs, which bind RT less well than correct dNTPs. Therefore,
RNase H activity may indirectly increase the fidelity of DNA
synthesis. Nature’s ploy of assigning two competing enzymatic
activities in one molecule is often found in DNA polymerases that
have both the DNA synthesis and endonuclease proofreading ac-
tivities, and the result is enhanced fidelity (30, 31). Wemay also take
advantage of such duality to target alternative sites for inhibition. In
addition to the inhibitor found by targeting the p51-p66 interface,
RNA oligonucleotides with sequences preferred by RNase H may
be modified with 2′-methyl, -fluoro, or -amine groups to resist
degradation and used to indirectly inhibit the DNA polymerase
activity of HIV-1 RT.
Materials and Methods
The materials and methods used in this study, including protein and nucleic
acid preparations; structure determination; assays for RNA/DNA hybrid
binding, RNA cleavage, andDNA synthesis; and virtual and experimental drug
screening, are described in detail in SI Appendix.
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